FDA Approved: PALIPERIDONE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for paliperidone filed by NorthStar RxLLC under ANDA205618.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

SUPPL AP for PALIPERIDONE (PALIPERIDONE)